DG INNOVATE PLC Logo

DG INNOVATE PLC

Develops sustainable tech for EV drivetrains and next-gen energy storage materials.

DGI | IL

Overview

Corporate Details

ISIN(s):
GB00BMZ3D204 (+2 more)
LEI:
21380058VQBP76M7TN11
Country:
United Kingdom
Address:
15 VICTORIA MEWS COTTINGLEY BUSINESS PARK, BD16 1PY BINGLEY
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

DG Innovate PLC is an advanced research and development company specializing in sustainable and environmentally considerate technologies for electric mobility and energy storage. The company pioneers and delivers patented solutions aimed at revolutionizing electric vehicle (EV) drivetrains and enhancing battery performance. Its core areas of innovation include advanced electric motor designs and the development of novel materials, such as hard carbon anodes, for next-generation energy storage systems.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-01-15 13:06
Board/Management Information
Directorate Changes & P80 Motor Development Update
English 9.1 KB
2024-12-31 13:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 7.2 KB
2024-12-31 08:00
Delisting Announcement
Intention to delist from London Stock Exchange
English 16.8 KB
2024-12-10 14:37
Share Issue/Capital Change
Result of Conditional Placing
English 15.7 KB
2024-12-10 14:08
Share Issue/Capital Change
Proposed Placing to raise approximately £500,000
English 111.8 KB
2024-11-29 18:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 11.0 KB
2024-11-27 08:00
Regulatory Filings
DGI to commence production of motors via EVage JV
English 19.5 KB
2024-11-20 08:00
Declaration of Voting Results & Voting Rights Announcements
Further re Director Subscriptions
English 11.1 KB
2024-11-18 08:00
Business and Financial Review
Cummins Pareta Collaboration
English 11.8 KB
2024-11-13 08:00
Business and Financial Review
Energy Storage Update
English 12.3 KB
2024-11-01 08:00
Regulatory Filings
Delivery of Industry-Leading 450kW Prototype Motor
English 12.7 KB
2024-10-31 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 12.9 KB
2024-10-16 08:00
Share Issue/Capital Change
£215,000 Director Subscriptions
English 30.8 KB
2024-09-30 08:00
Interim / Quarterly Report
Interim Results
English 356.6 KB
2024-09-17 18:11
Share Issue/Capital Change
Result of Retail Offer
English 27.0 KB

Automate Your Workflow. Get a real-time feed of all DG INNOVATE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DG INNOVATE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DG INNOVATE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland
ACHI
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG

Talk to a Data Expert

Have a question? We'll get back to you promptly.